A
Senior Director - West International Cluster, Global Rare BU
Contract type
Ongoing
Work mode
Hybrid · Zug, Switzerland
Experience
Lead / principal · Not stated
Level inferred from job title
Job description
Senior Director leading the West International Cluster commercial team for Alnylam's Global Rare Business Unit, with immediate focus on driving development of GIVLAARI and OXLUMO. Responsible for developing and executing all sales and marketing activities across the cluster of countries.
At a glance
- Employment
- Full-time · Employee (employment agreement)
- Work mode
- Hybrid · Zug, Switzerland
- Languages
- English
- Apply before
- November 13, 2027
What you'll do
- Support and challenge regional and local teams in tailoring the global strategy to the specific markets while maintaining global/regional alignment
- Allocate investment and drive and track focused execution of cross-functional tactics
- Share learnings and best practices across the Global Rare Business Unit
- Lead a team of Field Business Leaders (FBL) across a group of geographies
- Act as primary interface with local Country Managers and International TTR BU shared services (Regional Commercial, Business Operations and Market Access)
- Partner with Medical and Regional Marketing to ensure optimal alignment, insight sharing and communication
- Build and execute the Cluster tactical plan (e.g., sales force and HCP target group prioritization, congress activities, marketing materials)
- Participate in regional tactics as appropriate (e.g., European congresses)
- Manage the full Commercial Team for the specific geographies (Field Business Leaders and their KAMs)
- Maximize the commercial potential of Alnylam's assets through development and implementation of strategic/operational plans in collaboration with Global Rare marketing, Medical Affairs and Market Access teams
- Define, plan and set the commercial direction for the business within the Cluster, utilizing innovative techniques to drive increased customer value and market penetration
- Lead the cross-functional team providing vision, motivation, and support and coaching infrastructure to drive the business and achieve portfolio objectives
- Partner with Market Access and Country Managers to identify, develop, propose and execute local reimbursement plans, including alignment with adaptation of European pricing, reimbursement and access strategies
- Lead and build a high performing commercial team by hiring top talent, addressing talent gaps, upskilling and providing career guidance
- Deliver against agreed commercial and strategic objectives, as well as Quality, Compliance and risk management in the countries of the cluster
- Ensure all business activities are in line with company policies, procedures and local guidelines
- Build sustainable relationships with local healthcare stakeholders, function as main partner for local customers and local/international KOLs
- Ensure high quality revenue and volume forecasting and brand investment deployment for the cluster
- Develop and implement innovative, multichannel marketing strategies and tactics in the cluster, including planning and tracking of commercial spent investment
- Ensure deep local market and stakeholder insights to inform local tailoring of strategy and tactics and to help inform the global/regional strategy
- Contribute to the development of the Global strategic plan and annual tactical plans
- Ensure detailed pre-launch and post-launch tracking of agreed KPIs to allow early course correction and ensure execution of key tactics
What we're looking for
- Life Science degree or Business degree
- Extensive knowledge/experience of working in a bio/pharmaceutical commercial (Sales & Marketing) team
- Experience in collaboration in cross-functional teams
- Demonstrable commercial leadership experience in the biopharmaceutical industry such as a highly successful Sales Manager or Marketing Manager and a strong sales & marketing leader within the specialty therapeutics arena
- Track record of successful budget management with an understanding of revenue forecasting and expense budget planning and tracking
- Ability to build and drive a business, with innate 'market-making' capabilities and a natural self-starter, hands-on, entrepreneurial and innovative attitude
- Strong leadership qualities such as the ability to attract, motivate and retain talent and drive a culture of collaboration, engagement and motivation
- Ability to provide strategic input at Global level
- Outstanding knowledge of the Rare Disease space, including Market Access key success factors
- Strong network/matrix stakeholder communications skills with both regional and in-country teams
- Strong business and financial acumen
- Relentless external customer and patient focus
- Outstanding strategic thinking combined with strong execution leadership
- Inspirational leader, able to energize and motivate cross-functional teams and Sales Force
- Autonomous working style, pragmatic and operationally oriented, excellent planning and organizing skills
- Sense of urgency, ethics and responsibility
- Excellent command of written and spoken English
- Openness to travel approximately 60% domestically and some internationally
Nice to have
- Orphan drugs experience
Your team
Global Rare Business Unit - West International Cluster
Commercial team across a group of geographies, including Field Business Leaders and their KAMs; reports to the VP, International Rare Head.
Apply
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines. Based on Nobel Prize-winning science, RNAi therapeutics represent a clinically validated approach to treating diseases at their genetic source by interfering with mRNA that cause or contribute to disease.
Mission
To turn scientific possibility into reality by translating RNA interference (RNAi) into a new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases.
Key facts
- 2002
- Nasdaq: ALNY
- Led the translation of RNA interference (RNAi) into a new class of innovative medicines
- Based on Nobel Prize-winning science
What they value
- Equal employment opportunity
- Empowering employees to embrace their unique differences